华领医药-B荣获“格隆汇金格奖·年度卓越生物医药企业”奖

Core Viewpoint - The "Annual Outstanding Biopharmaceutical Company" award was presented to Hualing Pharmaceutical-B (02552.HK) during the "Technology Empowerment · Capital Breakthrough" online sharing session held by Gelonghui on December 22 [1] Group 1 - The award recognizes companies with independent core technologies, continuous innovation, and effective transformation of research results into clinical or commercial applications in the biopharmaceutical field [1] - The evaluation criteria for the award include technological innovation, research and development strength, and the ability to translate results into practical applications [1]